About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant part in this development.
With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”
May 17, 2013
greenovation Biotech GmbH and Biomeva GmbH sign Development, Manufacturing and Supply Agreement for GMP production of a protein with a novel expression platform
» [more]
May 16, 2013
Merck Serono Increases its Commitment to MS Ventures to € 100 million
» [more]
May 16, 2013
Strengthening EMBL-Argentine relations
» [more]
Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.
» Find further future events here
Increase your chances of getting your R&D project funded
Compete - get trained - succeed!
Click to learn more about HAE Accelerator
© 2012 BioRN Cluster Management GmbH • All rights reserved • Imprint & Legal Notice